Skip to content
FDA drug shortage status

Is Molnupiravir Capsule in shortage?

Molnupiravir Capsule is listed by FDA as being discontinued by at least one maker (updated Oct 20, 2026).

Being discontinuedFDA status
3packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Lagevrio, Capsule, 200 mg (NDC 0006-5055-06)
    Merck Sharp & Dohme LLCBeing discontinuedUpdated Oct 20, 2026Discontinued Oct 20, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 800-672-6372

  • Lagevrio, Capsule, 200 mg (NDC 0006-5055-07)
    Merck Sharp & Dohme LLCBeing discontinuedUpdated Oct 20, 2026Discontinued Oct 20, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 800-672-6372

  • Lagevrio, Capsule, 200 mg (NDC 0006-5055-09)
    Merck Sharp & Dohme LLCBeing discontinuedUpdated Oct 20, 2026Discontinued Oct 20, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 800-672-6372

Molnupiravir Capsule shortage questions

Is Molnupiravir Capsule in shortage?

Molnupiravir Capsule is listed by FDA as being discontinued by at least one maker (updated Oct 20, 2026).

What should I do if I can’t get Molnupiravir Capsule?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.